Biocryst Pharmaceuticals (BCRX) EBT Margin (2010 - 2026)
Biocryst Pharmaceuticals' EBT Margin came in at 36.41% for Q2 2026, up 32.44 percentage points from 3.97% a year earlier and up 497.25 percentage points from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) EBT Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biocryst Pharmaceuticals reported EBT Margin of -40.53%, down 34.75 percentage points year-over-year; for FY2025, it came in at 30.56%, up 49.86 percentage points from FY2024.
- EBT Margin has increased in each of the last five years, with a five-year change of +1056.92 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -19.29% in FY2024 (+48.97 pp), -68.26% in FY2023 (+21.97 pp), -90.24% in FY2022 (+25.44 pp) and -115.68% in FY2021 (+910.68 pp).
- The five-year range for quarterly EBT Margin is -460.84% (Q1 2026) to 61.00% (Q4 2025).
- Year-over-year, EBT Margin increased in seven of the last eight quarters, with an average year-over-year change of -24.71 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q4 2021 (a gain of 1398.50 percentage points), and the weakest in Q1 2026 (a drop of 461.36 percentage points).
- Business Quant data shows BCRX's EBT Margin at -460.84% (Q1 2026), 61.00% (Q4 2025) and 7.61% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn | 36.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.41% |
| Mar 31, 2026 | -460.84% |
| Dec 31, 2025 | 61.00% |
| Sep 30, 2025 | 7.61% |
| Jun 30, 2025 | 3.97% |
| Mar 31, 2025 | 0.52% |
| Dec 31, 2024 | -19.76% |
| Sep 30, 2024 | -11.48% |
| Jun 30, 2024 | -11.43% |
| Mar 31, 2024 | -37.75% |
| Dec 31, 2023 | -67.62% |
| Sep 30, 2023 | -41.29% |
| Jun 30, 2023 | -90.42% |
| Mar 31, 2023 | -76.57% |
| Dec 31, 2022 | -89.84% |
| Sep 30, 2022 | -54.07% |
| Jun 30, 2022 | -88.51% |
| Mar 31, 2022 | -148.06% |
| Dec 31, 2021 | -32.92% |
| Sep 30, 2021 | -143.44% |
API Access
Biocryst Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();